相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Staphylococcus Aureus Induces Osteoclastogenesis via the NF-kappa B Signaling Pathway
Li-Rong Ren et al.
MEDICAL SCIENCE MONITOR (2017)
Anti-inflammatory and anti-osteoarthritis effects of tectorigenin
Cheng-Long Wang et al.
BIOLOGY OPEN (2017)
Artesunate suppresses RANKL-induced osteoclastogenesis through inhibition of PLCγ1-Ca2+-NFATc1 signaling pathway and prevents ovariectomy-induced bone loss
Xiangzhou Zeng et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Alternative NF-κB Regulates RANKL-Induced Osteoclast Differentiation and Mitochondrial Biogenesis via Independent Mechanisms
Rong Zeng et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Short-term and long-term effects of osteoporosis therapies
Ian R. Reid
NATURE REVIEWS ENDOCRINOLOGY (2015)
Tectorigenin regulates adipogenic differentiation and adipocytokines secretion via PPARγ and IKK/NF-κB signaling
Qun-Yi Li et al.
PHARMACEUTICAL BIOLOGY (2015)
Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-kappa B as a therapeutic target
Tzu-hua Lin et al.
ACTA BIOMATERIALIA (2014)
The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-κB and NFATc1 signaling
Zanjing Zhai et al.
BIOMATERIALS (2014)
Loss of Cbl-PI3K interaction in mice prevents significant bone loss following ovariectomy
Naga Suresh Adapala et al.
BONE (2014)
Advances in the Regulation of Osteoclasts and Osteoclast Functions
B. F. Boyce
JOURNAL OF DENTAL RESEARCH (2013)
Public Health Impact of Osteoporosis
Jane A. Cauley
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2013)
Tectorigenin Attenuates Palmitate-Induced Endothelial Insulin Resistance via Targeting ROS-Associated Inflammation and IRS-1 Pathway
Qi Wang et al.
PLOS ONE (2013)
HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis
Yoshiteru Miyauchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway
Yeong-In Yang et al.
CARCINOGENESIS (2012)
An overview of the regulation of bone remodelling at the cellular level
Jasreen Kular et al.
CLINICAL BIOCHEMISTRY (2012)
Prevention of Wear Particle-Induced Osteolysis by a Novel V-ATPase Inhibitor Saliphenylhalamide through Inhibition of Osteoclast Bone Resorption
An Qin et al.
PLOS ONE (2012)
Physiology of the aging bone and mechanisms of action of bisphosphonates
Ligia J. Dominguez et al.
BIOGERONTOLOGY (2011)
TGF-β Inducible Early Gene 1 Regulates Osteoclast Differentiation and Survival by Mediating the NFATc1, AKT, and MEK/ERK Signaling Pathways
Muzaffer Cicek et al.
PLOS ONE (2011)
New and Emerging Antiresorptive Treatments in Osteoporosis
Lars Rejnmark et al.
CURRENT DRUG SAFETY (2011)
Use of bone turnover markers in clinical osteoporosis assessment in women: current issues and future options
K. Henriksen et al.
WOMENS HEALTH (2011)
The molecular mechanism behind bone remodelling: a review
Peter Proff et al.
CLINICAL ORAL INVESTIGATIONS (2009)
Tectorigenin Inhibits IFN-γ/LPS-induced Inflammatory Responses in Murine Macrophage RAW 264.7 Cells
Cheol-Ho Pan et al.
ARCHIVES OF PHARMACAL RESEARCH (2008)
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Hiroshi Takayanagi
NATURE REVIEWS IMMUNOLOGY (2007)
Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo
E Jimi et al.
NATURE MEDICINE (2004)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
Menopausal hormone replacement therapy and risk of ovarian cancer
JV Lacey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
分享论文
